Puchner et al., 2018 - Google Patents
Differences in the association of total versus local coronary artery calcium with acute coronary syndrome and culprit lesions in patients with acute chest pain: The …Puchner et al., 2018
View PDF- Document ID
- 17453291969164813103
- Author
- Puchner S
- Mayrhofer T
- Park J
- Lu M
- Liu T
- Maurovich-Horvat P
- Ghemigian K
- Bittner D
- Fleg J
- Udelson J
- Truong Q
- Hoffmann U
- Ferencik M
- Publication year
- Publication venue
- Atherosclerosis
External Links
Snippet
Background and aims Total coronary artery calcium (CAC) burden is associated with an increased cardiovascular risk, while local CAC may represent stable plaques. We determined differences in relationship of total CAC with acute coronary syndrome (ACS) and …
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0nMS4wJyBlbmNvZGluZz0naXNvLTg4NTktMSc/Pgo8c3ZnIHZlcnNpb249JzEuMScgYmFzZVByb2ZpbGU9J2Z1bGwnCiAgICAgICAgICAgICAgeG1sbnM9J2h0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnJwogICAgICAgICAgICAgICAgICAgICAgeG1sbnM6cmRraXQ9J2h0dHA6Ly93d3cucmRraXQub3JnL3htbCcKICAgICAgICAgICAgICAgICAgICAgIHhtbG5zOnhsaW5rPSdodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rJwogICAgICAgICAgICAgICAgICB4bWw6c3BhY2U9J3ByZXNlcnZlJwp3aWR0aD0nMzAwcHgnIGhlaWdodD0nMzAwcHgnIHZpZXdCb3g9JzAgMCAzMDAgMzAwJz4KPCEtLSBFTkQgT0YgSEVBREVSIC0tPgo8cmVjdCBzdHlsZT0nb3BhY2l0eToxLjA7ZmlsbDojRkZGRkZGO3N0cm9rZTpub25lJyB3aWR0aD0nMzAwLjAnIGhlaWdodD0nMzAwLjAnIHg9JzAuMCcgeT0nMC4wJz4gPC9yZWN0Pgo8dGV4dCB4PScxMzguMCcgeT0nMTcwLjAnIGNsYXNzPSdhdG9tLTAnIHN0eWxlPSdmb250LXNpemU6NDBweDtmb250LXN0eWxlOm5vcm1hbDtmb250LXdlaWdodDpub3JtYWw7ZmlsbC1vcGFjaXR5OjE7c3Ryb2tlOm5vbmU7Zm9udC1mYW1pbHk6c2Fucy1zZXJpZjt0ZXh0LWFuY2hvcjpzdGFydDtmaWxsOiMzQjQxNDMnID5DPC90ZXh0Pgo8dGV4dCB4PScxNjUuNicgeT0nMTcwLjAnIGNsYXNzPSdhdG9tLTAnIHN0eWxlPSdmb250LXNpemU6NDBweDtmb250LXN0eWxlOm5vcm1hbDtmb250LXdlaWdodDpub3JtYWw7ZmlsbC1vcGFjaXR5OjE7c3Ryb2tlOm5vbmU7Zm9udC1mYW1pbHk6c2Fucy1zZXJpZjt0ZXh0LWFuY2hvcjpzdGFydDtmaWxsOiMzQjQxNDMnID5hPC90ZXh0Pgo8cGF0aCBkPSdNIDE4OC40LDE0Ni4wIEwgMTg4LjQsMTQ1LjggTCAxODguNCwxNDUuNyBMIDE4OC40LDE0NS41IEwgMTg4LjMsMTQ1LjMgTCAxODguMywxNDUuMiBMIDE4OC4yLDE0NS4wIEwgMTg4LjEsMTQ0LjkgTCAxODguMCwxNDQuNyBMIDE4Ny45LDE0NC42IEwgMTg3LjcsMTQ0LjUgTCAxODcuNiwxNDQuNCBMIDE4Ny41LDE0NC4zIEwgMTg3LjMsMTQ0LjIgTCAxODcuMiwxNDQuMSBMIDE4Ny4wLDE0NC4xIEwgMTg2LjgsMTQ0LjAgTCAxODYuNywxNDQuMCBMIDE4Ni41LDE0NC4wIEwgMTg2LjMsMTQ0LjAgTCAxODYuMSwxNDQuMCBMIDE4Ni4wLDE0NC4xIEwgMTg1LjgsMTQ0LjEgTCAxODUuNiwxNDQuMiBMIDE4NS41LDE0NC4yIEwgMTg1LjMsMTQ0LjMgTCAxODUuMiwxNDQuNCBMIDE4NS4xLDE0NC41IEwgMTg0LjksMTQ0LjcgTCAxODQuOCwxNDQuOCBMIDE4NC43LDE0NC45IEwgMTg0LjcsMTQ1LjEgTCAxODQuNiwxNDUuMiBMIDE4NC41LDE0NS40IEwgMTg0LjUsMTQ1LjYgTCAxODQuNSwxNDUuNyBMIDE4NC40LDE0NS45IEwgMTg0LjQsMTQ2LjEgTCAxODQuNSwxNDYuMyBMIDE4NC41LDE0Ni40IEwgMTg0LjUsMTQ2LjYgTCAxODQuNiwxNDYuOCBMIDE4NC43LDE0Ni45IEwgMTg0LjcsMTQ3LjEgTCAxODQuOCwxNDcuMiBMIDE4NC45LDE0Ny4zIEwgMTg1LjEsMTQ3LjUgTCAxODUuMiwxNDcuNiBMIDE4NS4zLDE0Ny43IEwgMTg1LjUsMTQ3LjggTCAxODUuNiwxNDcuOCBMIDE4NS44LDE0Ny45IEwgMTg2LjAsMTQ3LjkgTCAxODYuMSwxNDguMCBMIDE4Ni4zLDE0OC4wIEwgMTg2LjUsMTQ4LjAgTCAxODYuNywxNDguMCBMIDE4Ni44LDE0OC4wIEwgMTg3LjAsMTQ3LjkgTCAxODcuMiwxNDcuOSBMIDE4Ny4zLDE0Ny44IEwgMTg3LjUsMTQ3LjcgTCAxODcuNiwxNDcuNiBMIDE4Ny43LDE0Ny41IEwgMTg3LjksMTQ3LjQgTCAxODguMCwxNDcuMyBMIDE4OC4xLDE0Ny4xIEwgMTg4LjIsMTQ3LjAgTCAxODguMywxNDYuOCBMIDE4OC4zLDE0Ni43IEwgMTg4LjQsMTQ2LjUgTCAxODguNCwxNDYuMyBMIDE4OC40LDE0Ni4yIEwgMTg4LjQsMTQ2LjAgTCAxODYuNCwxNDYuMCBaJyBzdHlsZT0nZmlsbDojMDAwMDAwO2ZpbGwtcnVsZTpldmVub2RkO2ZpbGwtb3BhY2l0eToxO3N0cm9rZTojMDAwMDAwO3N0cm9rZS13aWR0aDowLjBweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxOycgLz4KPHBhdGggZD0nTSAxODguNCwxNTQuMCBMIDE4OC40LDE1My44IEwgMTg4LjQsMTUzLjcgTCAxODguNCwxNTMuNSBMIDE4OC4zLDE1My4zIEwgMTg4LjMsMTUzLjIgTCAxODguMiwxNTMuMCBMIDE4OC4xLDE1Mi45IEwgMTg4LjAsMTUyLjcgTCAxODcuOSwxNTIuNiBMIDE4Ny43LDE1Mi41IEwgMTg3LjYsMTUyLjQgTCAxODcuNSwxNTIuMyBMIDE4Ny4zLDE1Mi4yIEwgMTg3LjIsMTUyLjEgTCAxODcuMCwxNTIuMSBMIDE4Ni44LDE1Mi4wIEwgMTg2LjcsMTUyLjAgTCAxODYuNSwxNTIuMCBMIDE4Ni4zLDE1Mi4wIEwgMTg2LjEsMTUyLjAgTCAxODYuMCwxNTIuMSBMIDE4NS44LDE1Mi4xIEwgMTg1LjYsMTUyLjIgTCAxODUuNSwxNTIuMiBMIDE4NS4zLDE1Mi4zIEwgMTg1LjIsMTUyLjQgTCAxODUuMSwxNTIuNSBMIDE4NC45LDE1Mi43IEwgMTg0LjgsMTUyLjggTCAxODQuNywxNTIuOSBMIDE4NC43LDE1My4xIEwgMTg0LjYsMTUzLjIgTCAxODQuNSwxNTMuNCBMIDE4NC41LDE1My42IEwgMTg0LjUsMTUzLjcgTCAxODQuNCwxNTMuOSBMIDE4NC40LDE1NC4xIEwgMTg0LjUsMTU0LjMgTCAxODQuNSwxNTQuNCBMIDE4NC41LDE1NC42IEwgMTg0LjYsMTU0LjggTCAxODQuNywxNTQuOSBMIDE4NC43LDE1NS4xIEwgMTg0LjgsMTU1LjIgTCAxODQuOSwxNTUuMyBMIDE4NS4xLDE1NS41IEwgMTg1LjIsMTU1LjYgTCAxODUuMywxNTUuNyBMIDE4NS41LDE1NS44IEwgMTg1LjYsMTU1LjggTCAxODUuOCwxNTUuOSBMIDE4Ni4wLDE1NS45IEwgMTg2LjEsMTU2LjAgTCAxODYuMywxNTYuMCBMIDE4Ni41LDE1Ni4wIEwgMTg2LjcsMTU2LjAgTCAxODYuOCwxNTYuMCBMIDE4Ny4wLDE1NS45IEwgMTg3LjIsMTU1LjkgTCAxODcuMywxNTUuOCBMIDE4Ny41LDE1NS43IEwgMTg3LjYsMTU1LjYgTCAxODcuNywxNTUuNSBMIDE4Ny45LDE1NS40IEwgMTg4LjAsMTU1LjMgTCAxODguMSwxNTUuMSBMIDE4OC4yLDE1NS4wIEwgMTg4LjMsMTU0LjggTCAxODguMywxNTQuNyBMIDE4OC40LDE1NC41IEwgMTg4LjQsMTU0LjMgTCAxODguNCwxNTQuMiBMIDE4OC40LDE1NC4wIEwgMTg2LjQsMTU0LjAgWicgc3R5bGU9J2ZpbGw6IzAwMDAwMDtmaWxsLXJ1bGU6ZXZlbm9kZDtmaWxsLW9wYWNpdHk6MTtzdHJva2U6IzAwMDAwMDtzdHJva2Utd2lkdGg6MC4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MTsnIC8+Cjwvc3ZnPgo= data:image/svg+xml;base64,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 [Ca] 0 title abstract description 183
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
- A61B6/481—Diagnostic techniques involving the use of contrast agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment; Prognosis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/345—Medical expert systems, neural networks or other automated diagnosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lee et al. | Prognostic implications of plaque characteristics and stenosis severity in patients with coronary artery disease | |
| Puchner et al. | Differences in the association of total versus local coronary artery calcium with acute coronary syndrome and culprit lesions in patients with acute chest pain: The coronary calcium paradox | |
| Blaha et al. | Absence of coronary artery calcification and all-cause mortality | |
| Hecht et al. | Clinical indications for coronary artery calcium scoring in asymptomatic patients: expert consensus statement from the Society of Cardiovascular Computed Tomography | |
| Greenland et al. | ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography | |
| Nadjiri et al. | Incremental prognostic value of quantitative plaque assessment in coronary CT angiography during 5 years of follow up | |
| Joshi et al. | 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial | |
| Puchner et al. | High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain: results from the ROMICAT-II trial | |
| Blankstein et al. | Predictors of coronary heart disease events among asymptomatic persons with low low-density lipoprotein cholesterol: MESA (Multi-Ethnic Study of Atherosclerosis) | |
| Yamamoto et al. | Noncalcified atherosclerotic lesions with vulnerable characteristics detected by coronary CT angiography and future coronary events | |
| Hulten et al. | Incremental prognostic value of coronary artery calcium score versus CT angiography among symptomatic patients without known coronary artery disease | |
| Youssef et al. | Coronary calcium: new insights, recent data, and clinical role | |
| Osborne-Grinter et al. | Association of coronary artery calcium score with qualitatively and quantitatively assessed adverse plaque on coronary CT angiography in the SCOT-HEART trial | |
| Oemrawsingh et al. | High-sensitivity troponin T in relation to coronary plaque characteristics in patients with stable coronary artery disease; results of the ATHEROREMO-IVUS study | |
| Yavne et al. | Investigating the link between ischemic heart disease and Behcet's disease: A cross-sectional analysis | |
| Ferencik et al. | Non-invasive fractional flow reserve derived from coronary computed tomography angiography in patients with acute chest pain: Subgroup analysis of the ROMICAT II trial | |
| Seifarth et al. | Correlation of concentrations of high-sensitivity troponin T and high-sensitivity C-reactive protein with plaque progression as measured by CT coronary angiography | |
| Chua et al. | Coronary artery calcium in primary prevention | |
| Olson et al. | Association between high-sensitive troponin I and coronary artery calcification in a Danish general population | |
| Wang et al. | Age-and gender-adjusted percentiles for number of calcified plaques in coronary artery calcium scanning | |
| Guaricci et al. | Prognostic relevance of subclinical coronary and carotid atherosclerosis in a diabetic and nondiabetic asymptomatic population | |
| Hui et al. | The value of plasma fibrillin-1 level in patients with spontaneous coronary artery dissection | |
| Kunimura et al. | Prognostic impact of concurrence of metabolic syndrome and chronic kidney disease in patients undergoing coronary intervention: involvement of coronary plaque composition | |
| Rumberger | Using noncontrast cardiac CT and coronary artery calcification measurements for cardiovascular risk assessment and management in asymptomatic adults | |
| Wang et al. | Prognostic value of coronary artery calcium score in patients with stable angina pectoris after percutaneous coronary intervention |